| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 12/25/2007 | US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 12/25/2007 | US7312344 Dimeric isoflavones |
| 12/25/2007 | US7312304 Somatostatin agonists |
| 12/25/2007 | US7312234 Chemokine receptor binding heterocyclic compounds |
| 12/25/2007 | US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 12/25/2007 | US7312219 Antidiabetic agents |
| 12/25/2007 | US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 12/21/2007 | WO2007144668A2 Process for the preparation of s-fluoromethyl-6, 9 -difluoro-11 -hydroxy-16 -methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates |
| 12/21/2007 | CA2654644A1 Novel process and intermediates |
| 12/21/2007 | CA2646980A1 Compositions comprising porphyra and methods of making and using thereof |
| 12/20/2007 | US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia |
| 12/20/2007 | US20070293528 non-steroidal partial activators and/or tissue-specific activators or inhibtors for androgen receptors, used for treating acne, alopecia, hirsutism, prostatic hyperplasia or prostate cancer |
| 12/20/2007 | US20070293474 Combination of a DPP IV inhibitor and a cardiovascular compound |
| 12/20/2007 | US20070293464 Substituted Pyrimidine Compositions and Methods of Use |
| 12/20/2007 | US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 12/20/2007 | US20070292532 Vanadium Compounds as Inhibitors of Phosphatases |
| 12/20/2007 | US20070292520 Pulmonary Insulin Crystals |
| 12/20/2007 | US20070292479 Film-shaped drug forms for use in the oral cavity (wafers) |
| 12/20/2007 | DE19943708B4 Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New C13-substituted estra-1,3,5 (10) -triene-3-yl-sulfamate, to their preparation and to pharmaceutical compositions containing these compounds, method |
| 12/20/2007 | DE102006027796A1 Flat form medicament preparation based on hydrophilic polymer disintegrates quickly in contact with moisture, useful e.g. to release active agent in body opening/body cavity e.g. for contraception, comprises active agent combination |
| 12/20/2007 | DE102004018441B4 D-Homo-17-chlor-16(17)en Steroide D-homo-17-chloro-16 (17) en steroids |
| 12/19/2007 | EP1867331A1 Triazole derivative and the use thereof |
| 12/19/2007 | EP1865990A1 Method of treating or preventing type-2 diabetes |
| 12/19/2007 | EP1865955A2 Method of treating men with testosterone supplement and 5alpha-reductase inhibitor |
| 12/19/2007 | EP1865944A2 Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people |
| 12/19/2007 | EP1865938A2 Dosing regimes for trans-clomiphene |
| 12/19/2007 | EP1865925A1 Buccal delivery system |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | EP1480651B1 Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery |
| 12/19/2007 | EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/19/2007 | EP1230369B1 Polypeptide hormone phosphatonin |
| 12/19/2007 | CN101090901A Hexahydropyridoisoqinolines as DPP-IV inhibitors |
| 12/19/2007 | CN101088487A Cosmetic or pharmaceutical composition comprising a condensation polymer, cosmetic treatment method employing said composition, said condensation polymer and preparation method |
| 12/19/2007 | CN100355728C Inhibitors of dipeptidyl peptidase IV |
| 12/19/2007 | CN100355429C Application of drynaria in the treatment of hyperthyroidism and its preparation |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | CA2489763C Pharmaceutical salts of reboxetine |
| 12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
| 12/18/2007 | CA2378087C New process for the preparation of n-(1,1-dimethylethyl)-4-[[5'-ethoxy-4-cis-[2-(4-morfolino)ethoxy]-2'-oxospiro[cyclohexan-1,3'-[h]indol]-1'(2'h)-yl]-sulfonyl]-3-methoxybenzamideand its salts |
| 12/18/2007 | CA2219070C Methods of preventing breast cancer |
| 12/13/2007 | WO2007142217A1 1-phenylpyridone derivative |
| 12/13/2007 | WO2007140894A1 5-aryl-substituted dihydropyridopyrimidines and dihydropyridazines and use thereof as mineral corticoid antagonists |
| 12/13/2007 | WO2007140619A1 Derivatized insulin oligomers |
| 12/13/2007 | WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
| 12/13/2007 | US20070287970 Method for systemic drug delivery through the nail |
| 12/13/2007 | US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | CA2655273A1 Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist |
| 12/13/2007 | CA2654126A1 Crystalline forms of 11.beta.-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17.alpha.-pregna-4,9-dien-3-one |
| 12/13/2007 | CA2652989A1 Derivatized insulin oligomers |
| 12/12/2007 | EP1864967A1 Method for preparing O-desmethyl-venlafaxine |
| 12/12/2007 | EP1863795A1 Substituted triazole derivatives as oxytocin antagonists |
| 12/12/2007 | EP1863464A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
| 12/12/2007 | EP1752452A9 Propane-1,3-dione derivative or its salt |
| 12/12/2007 | EP1309618B1 Leucine-based motif and clostridial neurotoxins |
| 12/12/2007 | EP1276738B1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 12/12/2007 | CN101087758A Indole derivatives useful as progesterone receptor modulators |
| 12/12/2007 | CN101085333A Traditional Chinese medicine preparation for treating hypothyroidism |
| 12/12/2007 | CN101085312A Traditional Chinese medicine for treating hyperdyroidism |
| 12/12/2007 | CN101085217A Traditional Chinese medicine composition for treating hypothyroidism |
| 12/12/2007 | CN101085207A Traditional Chinese medicine preparation for treating hyperthyroidism |
| 12/12/2007 | CN101085205A Traditional Chinese medicine composition for treating hyperthyroidism |
| 12/12/2007 | CN100354299C Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 12/12/2007 | CN100353997C Stabilized preparation containing protein |
| 12/11/2007 | US7307164 β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/11/2007 | US7307102 Administering selective estrogen receptor modulators that possesses tissue-specific ER agonist activity |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/06/2007 | WO2007139826A2 Method for elevating prolactin in mammals |
| 12/06/2007 | WO2007138362A1 Use of gpcr agonists to delay progression of diabetes |
| 12/06/2007 | WO2007137797A1 Gestagen combination and an insulin sensitizer for treating pcos |
| 12/06/2007 | WO2007118711B1 17α-SUBSTITUTED 4-(3-OXOESTRA-4,9-DIEN-11β-YL)-BENZOIC ACID, ITS DERIVATIVES AND PROCESS FOR ITS PRODUCTION |
| 12/06/2007 | WO2007098388A3 Oxa-steroids derivatives as selective progesterone receptor modulators |
| 12/06/2007 | US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands |
| 12/06/2007 | US20070281888 having an activity of growing vascular endothelial cells, promoting transcription form c-fos promoter, promoting transciption from VEGF promoter and/or an angiogenic activity; a polynucleotide encoding this polypeptide; for treating obstructive arteriosclerosis, peripheral vascular disorder, angina |
| 12/06/2007 | US20070280931 Antibody variants |
| 12/06/2007 | US20070280886 Diagnostics and Therapeutics for Diseases Associated with Adrenomedullin Receptor (Amdr) |
| 12/06/2007 | DE102006026026A1 Arzneimittel Drug |
| 12/06/2007 | CA2653072A1 Method for elevating prolactin in mammals |
| 12/05/2007 | EP1862469A2 New solid forms of mesoprogestin 11Beta-[4E-(hydroxyimino methyl)-phenyl]-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on |
| 12/05/2007 | EP1862468A1 Crystalline 11beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one |
| 12/05/2007 | EP1862450A2 Novel compounds |
| 12/05/2007 | EP1862165A2 Prevention and treatment of androgen-deprivation induced hot flashes |
| 12/05/2007 | EP1861089A1 Oral modified release formulations containing 8-prenylnaringenin for continuous estrogen support |
| 12/05/2007 | EP1368318B1 Calcilytic compounds |
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 12/05/2007 | CN101083992A Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| 12/05/2007 | CN101081203A Method of increasing testosterone and related steroid concentrations in women |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352804C 酰胺衍生物 Amide derivatives |
| 12/05/2007 | CN100352505C A combination of FBPase Inhibitors and insulin sensitizers for the treatment of diabetes |
| 12/05/2007 | CN100352478C Novel use of bighead atractylodes rhizome in pharmacy |
| 12/05/2007 | CN100352453C Refined extractive of cassah silkworm and preparation method |
| 12/05/2007 | CN100352437C Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 12/04/2007 | US7304155 Nonsteroid; enantiomers are selective antagonists of the estrogen beta receptor relative to the alpha receptor; tissue selectivity; fewer estrogen-related side effects; menopause, osteoporosis, hormone replacent therapy, contraceptive, endometriosis; 10-aminoalkyloxyphenyl benzo[b]fluorene 2,8-diols |
| 12/04/2007 | US7304090 Using fluorescein; polycystic kidney disease, diarrhea, antiarrhythmia agents, antitumor agents, contraceptice |
| 12/04/2007 | US7304072 Spiro compounds |
| 12/04/2007 | US7304029 Inducing a neuroprotective effect of rescuing neurons destined to degenerate or die as a result of hypoxia or ischemia in a brain of a patient by administering growth hormone centrally to the brain of the patient |
| 11/29/2007 | WO2007136776A2 Pyrimidine low molecular weight ligands for modulating hormone receptors |
| 11/29/2007 | WO2007136103A1 Antitumor agent for thyroid cancer |
| 11/29/2007 | WO2007135350A1 Benzotriazepinone derivatives |